Screener
Tarsus Pharmaceuticals, Inc. TARS Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Inventory | 4,377 | 4,372 |
| Other receivables | 2,281 | 2,052 |
| Prepaid expenses | 9,613 | 13,473 |
| Total current assets | 561,989 | 522,782 |
| Restricted cash, non-current | 2,001 | 2,002 |
| Inventory, non-current | 2,525 | 2,532 |
| Property and equipment, net | 20,489 | 11,665 |
| Intangible assets, net | 6,885 | 7,366 |
Item 1. Financial Statements
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s total current assets?
- Tarsus Pharmaceuticals, Inc. (TARS) reported total current assets of $561.99M in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s total current assets increased by 18.5% year-over-year, from $474.43M to $561.99M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s total current assets has grown at a 25.1% compound annual growth rate (CAGR), from $170.66M to $522.78M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude